Volume 63, Issue 6, Pages (June 2003)

Slides:



Advertisements
Similar presentations
Volume 69, Issue 11, Pages (June 2006)
Advertisements

Urine Potassium Excretion, Kidney Failure, and Mortality in CKD
Volume 69, Issue 11, Pages (June 2006)
Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 81, Issue 5, Pages (March 2012)
Plasma sodium and hypertension
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Volume 65, Issue 5, Pages (May 2004)
Volume 93, Issue 4, Pages (April 2018)
Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients  G.A. Block, P. Raggi, A. Bellasi, L. Kooienga,
Paul W. Eggers, Dorothy Gohdes, Jacqueline Pugh  Kidney International 
Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets  David M. Spiegel, Kate Brady  Kidney.
Pharmacokinetics and pharmacodynamics of oral tolvaptan in patients with varying degrees of renal function  Susan E. Shoaf, Patricia Bricmont, Suresh.
Peter Rossing, Philip Hougaard, Hans-Henrik Parving 
Type of vascular access and mortality in U.S. hemodialysis patients
Francesco Paolo Schena  Kidney International 
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real?  S. Andrulli, S. Di Filippo, F. Locatelli 
Volume 68, Issue 4, Pages (October 2005)
Volume 77, Issue 1, Pages 5-6 (January 2010)
Volume 84, Issue 5, Pages (November 2013)
Volume 54, Issue 4, Pages (October 1998)
Proinflammatory effects of iron sucrose in chronic kidney disease
Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion  Lynda A. Frassetto, Eileen Nash,
Volume 70, Issue 11, Pages (December 2006)
Volume 77, Issue 2, Pages (January 2010)
The epidemiology of chronic kidney disease
Volume 71, Issue 11, Pages (June 2007)
Temporal trends in the incidence of kidney stone disease
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
U-shaped effect of eGFR and mortality
Body size and outcomes on peritoneal dialysis in the United States
Volume 70, Issue 12, Pages (December 2006)
Volume 81, Issue 5, Pages (March 2012)
Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease  Joan C. Lo, Glenn M. Chertow, Alan S. Go, Chi-Yuan.
Use of a probioitic to decrease enteric hyperoxaluria
Melamine toxicity: one more culprit in calcium kidney lithiasis
Volume 86, Issue 3, Pages (September 2014)
Volume 70, Issue 12, Pages (December 2006)
Fructose intake as a risk factor for kidney stone disease
Volume 72, Issue 1, Pages 8-10 (July 2007)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Abdulla K. Salahudeen, Erwin H. Fleischmann, John D. Bower 
Alternate-day dialysis may be needed for hemodialysis patients
Methods for guideline development
Volume 93, Issue 1, Pages (January 2018)
Volume 67, Issue 4, Pages (April 2005)
Volume 78, Issue 5, Pages (September 2010)
The global challenge of chronic kidney disease
Nephrology Crossword: Glomerulonephritis
Volume 73, Issue 8, Pages (April 2008)
Volume 58, Issue 3, Pages (September 2000)
Neesh Pannu, Braden Manns, Helen Lee, Marcello Tonelli 
Prehypertension: is it relevant for nephrologists?
Volume 67, Issue 6, Pages (June 2005)
Kathy E. Sietsema, Antonino Amato, Sharon G. Adler, Eric P. Brass 
Phosphate binders on iron basis: A new perspective?
Volume 61, Issue 1, Pages (January 2002)
Volume 60, Issue 3, Pages (September 2001)
Volume 75, Issue 1, Pages (January 2009)
Volume 69, Issue 11, Pages (June 2006)
Volume 62, Issue 5, (November 2002)
James B. Young, Hans-Hellmut Neumayer, Robert D. Gordon 
Vitamin D deficiency and anemia in early chronic kidney disease
Wendy E. Hoy, Megan Rees, Emma Kile, John D. Mathews, Zhiqiang Wang 
WASH—World Action on Salt and Health
Volume 87, Issue 6, Pages (June 2015)
The effect of a shift in sodium intake on renal hemodynamics is determined by body mass index in healthy young men  J.A. Krikken, A.T. Lely, S.J.L. Bakker,
Sugar-sweetened beverages and chronic disease
Volume 71, Issue 3, Pages (February 2007)
Presentation transcript:

Volume 63, Issue 6, Pages 2200-2206 (June 2003) Cross-sectional and prospective data on urinary calcium and urinary stone disease  Massimo Cirillo, Davide Stellato, Paolo Panarelli, Martino Laurenzi, Natale G. De Santo, Gubbio Study Research Group  Kidney International  Volume 63, Issue 6, Pages 2200-2206 (June 2003) DOI: 10.1046/j.1523-1755.2003.t01-2-00003.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Overnight urinary calcium (Ca) excretion and measured 24-hour urinary calcium excretion of two different days in a subgroup of the study cohort (72 men and 76 women). Rank order correlation coefficient = 0.387, P < 0.001. Kidney International 2003 63, 2200-2206DOI: (10.1046/j.1523-1755.2003.t01-2-00003.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 Percent with urinary stone disease (USD) by quartile of urinary calcium (Ca) excretion at baseline. Number of persons per quartile (1 to 4): men (■) = 364, 366, 367, and 361; women (□) = 447, 454, 450, and 448; urinary calcium excretion (μmol/hour, minimum-maximum): men = 4–115, 116–177, 178–252, and 253–599, women = 4–101, 102–149, 150–219, and 220–598. P < 0.001 in men and = 0.009 in women for linear trend by chi-square analysis. Kidney International 2003 63, 2200-2206DOI: (10.1046/j.1523-1755.2003.t01-2-00003.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 Relative risk with lower limit of 95% CI for urinary stone disease (USD) prevalence over mean urinary calcium (Ca) excretion in quartiles 2 to 4 of baseline urinary calcium excretion in comparison to risk for USD prevalence in quartile 1 (risk = 1). Analyses were done in men and women combined with control for gender, age, body mass index, parental history of USD, urinary excretion of urea, sodium, and potassium. Risk was significantly increased in quartiles 3 and 4. P for linear trend in relative risk = 0.021. Kidney International 2003 63, 2200-2206DOI: (10.1046/j.1523-1755.2003.t01-2-00003.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Percent with urinary stone disease (USD) incidence by quartile of baseline urinary calcium (Ca) excretion. Number of persons per quartile (1 to 4): men (■) = 346, 344, 341, and 319; women (□) = 435, 438, 425, and 422; urinary calcium excretion (μmol/hour, minimum-maximum): men = 4–115, 116–177, 178–252, and 253–599; women = 4–101, 102–149, 150–219, and 220–598. P = 0.001 in men and 0.044 in women for linear trend by chi-square analysis. Kidney International 2003 63, 2200-2206DOI: (10.1046/j.1523-1755.2003.t01-2-00003.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Relative risk with lower limit of 95% CI for urinary stone disease (USD) incidence over mean urinary calcium excretion in quartiles 2 to 4 of baseline urinary calcium excretion in comparison to risk for USD incidence in quartile 1 (risk = 1). Analyses were done in men and women combined with control for gender, age, body mass index, parental history of USD, urinary excretion of urea, sodium, and potassium. Risk was significantly increased in quartile 4. P for linear trend in relative risk = 0.003. Kidney International 2003 63, 2200-2206DOI: (10.1046/j.1523-1755.2003.t01-2-00003.x) Copyright © 2003 International Society of Nephrology Terms and Conditions